‹‹82››.
McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context— a systematic review of the literature.‹‹83››.
Lobel EZ, Korelitz BI. Postendoscopy syndrome: «the doctor never talked to me.»‹‹84››.
McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context— a systematic review of the literature.‹‹85››.
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.‹‹86››.
Manner H, Plum N, Pech O, Ell C, Enderle MD. Colon explosion during argon plasma coagulation.‹‹87››.
Ko CW, Dominitz JA. Complications of colonoscopy: magnitude and management.‹‹88››.
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Ser vices Task Force.‹‹89››.
van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.‹‹90››.
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.‹‹91››.
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.‹‹92››.
Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates.‹‹93››.
Ling BS, Trauth JM, Fine MJ, et al. Informed decision-making and colorectal cancer screening: is it occurring in primary care?‹‹94››.
Ling BS, Trauth JM, Fine MJ, et al. Informed decision-making and colorectal cancer screening: is it occurring in primary care?‹‹95››.
Brett AS. Flexible sigmoidoscopy for colorectal cancer screening: more evidence, persistent ironies.‹‹96››.
Yabroff KR, Klabunde CN, Yuan G, et al. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J‹‹97››.
Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates.‹‹98››.
Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening programs: population contact strategies, testing methods and screening rates.‹‹99››.
Butterfi eld S. Changes coming for colon cancer screening.‹‹100››.
Rosenthal E. The $2.7 trillion medical bill: colonoscopies explain why U.S. leads the world in health expenditures.‹‹101››.
Whoriskey P, Keating D. How a secretive panel uses data that distorts doctors’ pay.‹‹102››.
US Government Accountability Office. Medicare: action needed to address higher use of anatomic pathology ser vices by providers who self-refer. GAO-13-445. http://www.gao.gov/products/GAO-13-445. June 24, 2013. Accessed March 12, 2015.